The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Visceral Pain Treatment Market Research Report 2024
Synopsis
The global Visceral Pain Treatment market was valued at US$ 13430 million in 2023 and is anticipated to reach US$ 19220 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Visceral Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Visceral Pain Treatment.
Report Scope
The Visceral Pain Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Visceral Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Visceral Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Addex Therapeutics Ltd
Astellas Pharma Inc.
Chromocell Corporation
GIcare Pharma Inc
Grunenthal GmbH
Medestea Research & Production S.p.A.
Neurim Pharmaceuticals Ltd
Pfizer Inc.
Segment by Type
HS-665
CC-8464
BLU-5937
APD-371
Others
Segment by Application
In-patient
Out-patient
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Visceral Pain Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Visceral Pain Treatment market was valued at US$ 13430 million in 2023 and is anticipated to reach US$ 19220 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Visceral Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Visceral Pain Treatment.
Report Scope
The Visceral Pain Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Visceral Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Visceral Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Addex Therapeutics Ltd
Astellas Pharma Inc.
Chromocell Corporation
GIcare Pharma Inc
Grunenthal GmbH
Medestea Research & Production S.p.A.
Neurim Pharmaceuticals Ltd
Pfizer Inc.
Segment by Type
HS-665
CC-8464
BLU-5937
APD-371
Others
Segment by Application
In-patient
Out-patient
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Visceral Pain Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Visceral Pain Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 HS-665
1.2.3 CC-8464
1.2.4 BLU-5937
1.2.5 APD-371
1.2.6 Others
1.3 Market by Application
1.3.1 Global Visceral Pain Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 In-patient
1.3.3 Out-patient
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Visceral Pain Treatment Market Perspective (2019-2030)
2.2 Visceral Pain Treatment Growth Trends by Region
2.2.1 Global Visceral Pain Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Visceral Pain Treatment Historic Market Size by Region (2019-2024)
2.2.3 Visceral Pain Treatment Forecasted Market Size by Region (2025-2030)
2.3 Visceral Pain Treatment Market Dynamics
2.3.1 Visceral Pain Treatment Industry Trends
2.3.2 Visceral Pain Treatment Market Drivers
2.3.3 Visceral Pain Treatment Market Challenges
2.3.4 Visceral Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Visceral Pain Treatment Players by Revenue
3.1.1 Global Top Visceral Pain Treatment Players by Revenue (2019-2024)
3.1.2 Global Visceral Pain Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Visceral Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Visceral Pain Treatment Revenue
3.4 Global Visceral Pain Treatment Market Concentration Ratio
3.4.1 Global Visceral Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Visceral Pain Treatment Revenue in 2023
3.5 Visceral Pain Treatment Key Players Head office and Area Served
3.6 Key Players Visceral Pain Treatment Product Solution and Service
3.7 Date of Enter into Visceral Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Visceral Pain Treatment Breakdown Data by Type
4.1 Global Visceral Pain Treatment Historic Market Size by Type (2019-2024)
4.2 Global Visceral Pain Treatment Forecasted Market Size by Type (2025-2030)
5 Visceral Pain Treatment Breakdown Data by Application
5.1 Global Visceral Pain Treatment Historic Market Size by Application (2019-2024)
5.2 Global Visceral Pain Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Visceral Pain Treatment Market Size (2019-2030)
6.2 North America Visceral Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Visceral Pain Treatment Market Size by Country (2019-2024)
6.4 North America Visceral Pain Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Visceral Pain Treatment Market Size (2019-2030)
7.2 Europe Visceral Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Visceral Pain Treatment Market Size by Country (2019-2024)
7.4 Europe Visceral Pain Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Visceral Pain Treatment Market Size (2019-2030)
8.2 Asia-Pacific Visceral Pain Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Visceral Pain Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Visceral Pain Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Visceral Pain Treatment Market Size (2019-2030)
9.2 Latin America Visceral Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Visceral Pain Treatment Market Size by Country (2019-2024)
9.4 Latin America Visceral Pain Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Visceral Pain Treatment Market Size (2019-2030)
10.2 Middle East & Africa Visceral Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Visceral Pain Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Visceral Pain Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Company Detail
11.1.2 Addex Therapeutics Ltd Business Overview
11.1.3 Addex Therapeutics Ltd Visceral Pain Treatment Introduction
11.1.4 Addex Therapeutics Ltd Revenue in Visceral Pain Treatment Business (2019-2024)
11.1.5 Addex Therapeutics Ltd Recent Development
11.2 Astellas Pharma Inc.
11.2.1 Astellas Pharma Inc. Company Detail
11.2.2 Astellas Pharma Inc. Business Overview
11.2.3 Astellas Pharma Inc. Visceral Pain Treatment Introduction
11.2.4 Astellas Pharma Inc. Revenue in Visceral Pain Treatment Business (2019-2024)
11.2.5 Astellas Pharma Inc. Recent Development
11.3 Chromocell Corporation
11.3.1 Chromocell Corporation Company Detail
11.3.2 Chromocell Corporation Business Overview
11.3.3 Chromocell Corporation Visceral Pain Treatment Introduction
11.3.4 Chromocell Corporation Revenue in Visceral Pain Treatment Business (2019-2024)
11.3.5 Chromocell Corporation Recent Development
11.4 GIcare Pharma Inc
11.4.1 GIcare Pharma Inc Company Detail
11.4.2 GIcare Pharma Inc Business Overview
11.4.3 GIcare Pharma Inc Visceral Pain Treatment Introduction
11.4.4 GIcare Pharma Inc Revenue in Visceral Pain Treatment Business (2019-2024)
11.4.5 GIcare Pharma Inc Recent Development
11.5 Grunenthal GmbH
11.5.1 Grunenthal GmbH Company Detail
11.5.2 Grunenthal GmbH Business Overview
11.5.3 Grunenthal GmbH Visceral Pain Treatment Introduction
11.5.4 Grunenthal GmbH Revenue in Visceral Pain Treatment Business (2019-2024)
11.5.5 Grunenthal GmbH Recent Development
11.6 Medestea Research & Production S.p.A.
11.6.1 Medestea Research & Production S.p.A. Company Detail
11.6.2 Medestea Research & Production S.p.A. Business Overview
11.6.3 Medestea Research & Production S.p.A. Visceral Pain Treatment Introduction
11.6.4 Medestea Research & Production S.p.A. Revenue in Visceral Pain Treatment Business (2019-2024)
11.6.5 Medestea Research & Production S.p.A. Recent Development
11.7 Neurim Pharmaceuticals Ltd
11.7.1 Neurim Pharmaceuticals Ltd Company Detail
11.7.2 Neurim Pharmaceuticals Ltd Business Overview
11.7.3 Neurim Pharmaceuticals Ltd Visceral Pain Treatment Introduction
11.7.4 Neurim Pharmaceuticals Ltd Revenue in Visceral Pain Treatment Business (2019-2024)
11.7.5 Neurim Pharmaceuticals Ltd Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Detail
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Visceral Pain Treatment Introduction
11.8.4 Pfizer Inc. Revenue in Visceral Pain Treatment Business (2019-2024)
11.8.5 Pfizer Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
